Skip to main content

GABELLI FUNDS LLC

Position in NEO — Neogenomics Inc

CIK 1081407 Rye, NY

Position in NEO

as of Mar 31, 2026 · filed May 14, 2026
Position Value
$812,490
-$586,950 QoQ
Shares Held
109,500
-8.0% QoQ
Ownership
0.084%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
20 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NEO Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Mar 31, 2026

GABELLI FUNDS LLC holds $32,264,397 across 16 Diagnostics & Research names. NEO ranks #9 (2.5% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in NEO

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $812,490 109,500
2025-12-31 $1,399,440 119,000
2025-09-30 $918,680 119,000
2025-06-30 $869,890 119,000
2025-03-31 $939,510 99,000
2024-12-31 $230,720 14,000
2024-09-30 $265,500 18,000
2024-06-30 $249,660 18,000
2024-03-31 $282,960 18,000
2022-09-30 $241,080 28,000
2022-06-30 $391,200 48,000
2022-03-31 $591,705 48,700
2021-12-31 $1,525,164 44,700
2021-09-30 $2,156,328 44,700
2021-06-30 $2,064,269 45,700
2021-03-31 $2,179,996 45,200
2020-12-31 $3,217,478 59,760
2020-09-30 $2,423,673 65,700
2020-06-30 $2,741,730 88,500
2020-03-31 $1,656,600 60,000